W ramach programu Profesorów Wizytujących, będącego jednym z działań projektu Inicjatywa Doskonałości – Uczelnia Badawcza, gościć będziemy prof. Bena Boyda (Monash University, Australia), który wygłosi wykład otwarty pt. „Understanding lipid self-assembly and applications to drug delivery”.
Zapraszamy wszystkich zainteresowanych pracowników i studentów.
Biogram
Ben Boyd is a colloid and physical chemist with PhD from the University of Melbourne. After industry experience in the explosives and pharmaceutical industries, he commenced an academic position at Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University in Australia and is currently an ARC Laureate Research Fellow. His research is at the intersection of colloid science and pharmaceutical science, and focuses on colloidal and structural aspects of lipids and lipid self- assembly during digestion, colloidal drug delivery and his group is active in developing new synchrotron and spectroscopy-based characterization approaches for lipid and solid-state systems. He is a recipient of the 2021 Lifetime Contribution Award from the Australian Synchrotron, the 2020 Eureka Prize for Innovative Use of Technology, and the 2024 Dale E Wurster Research in Pharmaceutics award from the American association of Pharmaceutical Sciences (AAPS) among others. He is an elected Fellows of AAPS and the Controlled Release Society, and was President of the CRS (representing over 5000 drug delivery scientists globally) from 2021-2022. He maintains an affiliate Professor position at Department of Pharmacy, University of Copenhagen and is an adjunct Research Professor at the Department of Materials Science and Engineering at Monash University.
Tematyka wykładu
Lyotropic liquid crystals are an amazing material. Consisting of primarily lipid and water, they have a wide range of attributes not found together in a single material. They offer biocompatibility, a range of rheological properties from dispersions with the viscosity of water up to cubic phase almost solid gels, compartmentalisation of hydrophilic cargo and the possibility to trigger reversible changes in drug release. With these highly attractive properties for drug delivery it is surprising that very few products are actually on the market based on this technology. In this presentation I will aim to provide an appreciation of the potential applications of lyotropic liquid crystal systems, and a view to the limitations but also opportunities they present for the future.
